Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Supporting Women's Autonomy in Prenatal Testing.

Literature DB >> 28792882

Supporting Women's Autonomy in Prenatal Testing.

Josephine Johnston¹, Ruth M Farrell¹, Erik Parens¹.

Abstract

Entities: Disease Species

Mesh：

Year: 2017 PMID： 28792882 PMCID： PMC5688876 DOI： 10.1056/NEJMp1703425

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

× No keyword cloud information.

4 in total

1. Genome-wide copy number analysis on DNA from fetal cells isolated from the blood of pregnant women.

Authors: Steen Kølvraa; Ripudaman Singh; Elizabeth A Normand; Sadeem Qdaisat; Ignatia B van den Veyver; Laird Jackson; Lotte Hatt; Palle Schelde; Niels Uldbjerg; Else Marie Vestergaard; Li Zhao; Rui Chen; Chad A Shaw; Amy M Breman; Arthur L Beaudet
Journal: Prenat Diagn Date: 2016-11-18 Impact factor: 3.050

Review 2. The Promise and Peril of Precision Medicine: Phenotyping Still Matters Most.

Authors: Jaeger P Ackerman; Daniel C Bartos; Jamie D Kapplinger; David J Tester; Brian P Delisle; Michael J Ackerman
Journal: Mayo Clin Proc Date: 2016-10-08 Impact factor: 7.616

3. Effect of enhanced information, values clarification, and removal of financial barriers on use of prenatal genetic testing: a randomized clinical trial.

Authors: Miriam Kuppermann; Sherri Pena; Judith T Bishop; Sanae Nakagawa; Steven E Gregorich; Anita Sit; Juan Vargas; Aaron B Caughey; Susan Sykes; Lasha Pierce; Mary E Norton
Journal: JAMA Date: 2014-09-24 Impact factor: 56.272

4. Women's experiences receiving abnormal prenatal chromosomal microarray testing results.

Authors: Barbara A Bernhardt; Danielle Soucier; Karen Hanson; Melissa S Savage; Laird Jackson; Ronald J Wapner
Journal: Genet Med Date: 2012-09-06 Impact factor: 8.822

4 in total

6 in total

6. External Quality Assessment of Maternal Serum Levels of Alpha-Fetoprotein, Free Beta-Human Chorionic Gonadotropin, and Unconjugated Estriol in Detecting Down Syndrome and Neural Tube Defects in the Second Trimester of 87 Maternal Serum Samples, Based on 105-139 Days.

Authors: Yiming Chen; Yijie Chen; Yezhen Shi; Wenwen Ning; Xiaoying Wang; Liyao Li; Huimin Zhang
Journal: Med Sci Monit Date: 2022-04-13

6 in total

Supporting Women's Autonomy in Prenatal Testing.

1. Genome-wide copy number analysis on DNA from fetal cells isolated from the blood of pregnant women.

Review 2. The Promise and Peril of Precision Medicine: Phenotyping Still Matters Most.

3. Effect of enhanced information, values clarification, and removal of financial barriers on use of prenatal genetic testing: a randomized clinical trial.

4. Women's experiences receiving abnormal prenatal chromosomal microarray testing results.

1. Genetic Counselors' Perspectives About Cell-Free DNA: Experiences, Challenges, and Expectations for Obstetricians.

2. Ethical and counseling challenges in prenatal exome sequencing.

3. Prenatal Genetic Screening and Potential Complicity in Abortion: Considerations for Catholic Health Care.

Review 4. Genetic Counseling and Genome Sequencing in Pediatric Rare Disease.

Review 5. Supporting Patient Autonomy and Informed Decision-Making in Prenatal Genetic Testing.

6. External Quality Assessment of Maternal Serum Levels of Alpha-Fetoprotein, Free Beta-Human Chorionic Gonadotropin, and Unconjugated Estriol in Detecting Down Syndrome and Neural Tube Defects in the Second Trimester of 87 Maternal Serum Samples, Based on 105-139 Days.